Memory Loss: New Treatment on the Horizon

October 30, 2018
memory loss

Most people experience more moments than they can recall. From our first steps to dinner last night, we often have difficulty remembering all of the details from each day. Fortunately, the mind subconsciously stores many of these special moments as memories to be triggered by or associated with specific environmental factors for later recollection.

With each unique memory being more precious than the last, memory loss can be a frustrating experience to endure; however, cutting-edge research may provide new treatment opportunities and hope for patients diagnosed with mild cognitive impairment.

memory loss

First, what is mild cognitive impairment?

According to Mayo Clinic, memory loss, or mild cognitive impairment, is the stage between expected cognitive decline and aging, and the more serious decline of dementia. This condition affects over 20% of the U.S. population over the age of 65, and can often be the early onset of other cognitive diseases, such Alzheimer’s disease.

How is memory loss treated?

Since Dr. Alois Alzheimer first linked microscopic brain formations to memory loss in 1906, scientists have been searching for new, more effective ways to treat patients suffering from cognitive impairment. Due to the complicated nature of the condition, it wasn’t until the mid-1990’s that treatment options first emerged, with the FDA approval of a drug called tacrine (Cognex).

Based on information from the Alzheimer’s Association, there are two primary types of medication assigned to treat cognitive impairment symptoms: cholinesterase inhibitors and memantine. Cholinesterase inhibitors are prescribed to treat early to moderate stage memory loss or Alzheimer’s disease by helping prevent the breakdown of chemicals messengers used to stimulate learning and memory, while memantine is used to treat severe Alzheimer’s disease to improve daily function and information processing.

memory loss

Is there a cure for memory loss and dementia?

Unfortunately, there is no known cure for these conditions. Physicians at ActivMed are looking to change this reality by continually seeking new treatment options for patients diagnosed with mild cognitive impairment. If you or someone you know has experienced memory loss, or has been diagnosed with Alzheimer’s disease, you may be eligible to participate in clinical research! Qualified candidates who decide to participate will receive study-related visits and lab work at no cost, as well as receive compensation for travel. To learn more on how you can be involved, CLICK HERE.

Share!
×
Beverly, MA

×
Methuen, MA

×
Portsmouth, NH

×
Lawrence, MA

×